Pancreatic Cancer Research

ResearcherJiaxing UniversityNo recent work listed

Liu Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6467-0781; OpenAlex author ID A5101577066. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers

Papers 3

  1. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study. Last author DOI 10.1155/2021/8882129↗
  2. Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Co-author DOI 10.12659/msm.930545↗
  3. Gain of microRNA-103 triggers metastatic behavior by targeting ubiquitin specific peptidase 10 in pancreatic cancer. Co-author PMID 31933936↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dawei Jiang · 2 shared papers, 2019–2021 · strength 0.27
  2. Min Cai · 2 shared papers, 2019–2021 · strength 0.27
  3. Huangbao Li · 1 shared paper, 2021 · strength 0.16
  4. Fengqing Zhao · 1 shared paper, 2021 · strength 0.16
  5. Lan Shen · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.